{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:22:40Z","timestamp":1789050160473,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["445704496"],"award-info":[{"award-number":["445704496"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.radonc.2023.109694","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T21:23:00Z","timestamp":1683321780000},"page":"109694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T"],"prefix":"10.1016","volume":"184","author":[{"given":"Nikolaus","family":"von Knebel Doeberitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Breitling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdjan","family":"Maksimovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Gra\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Unterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bendszus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Ladd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Korzowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Goerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Paech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109694_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109694_b0010","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/ijc.34131","article-title":"Changing paradigms in oncology: toward noncytotoxic treatments for advanced gliomas","volume":"151","author":"von Knebel","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2023.109694_b0015","doi-asserted-by":"crossref","first-page":"6828396","DOI":"10.1155\/2018\/6828396","article-title":"Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas","volume":"2018","author":"Zikou","year":"2018","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.radonc.2023.109694_b0020","doi-asserted-by":"crossref","unstructured":"Henriksen OM, del Mar \u00c1lvarez-Torres M, Figueiredo P, Hangel G, Keil VC, Nechifor RE, Riemer F, Schmainda KM, Warnert EAH, Wiegers EC, Booth TC. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 1: Perfusion and Diffusion Techniques. 2022;12. doi: 10.3389\/fonc.2022.810263.","DOI":"10.3389\/fonc.2022.810263"},{"key":"10.1016\/j.radonc.2023.109694_b0025","doi-asserted-by":"crossref","unstructured":"Booth TC, Wiegers EC, Warnert EAH, Schmainda KM, Riemer F, Nechifor RE, Keil VC, Hangel G, Figueiredo P, \u00c1lvarez-Torres MDM, Henriksen OM. High-Grade Glioma Treatment Response Monitoring Biomarkers: A Position Statement on the Evidence Supporting the Use of Advanced MRI Techniques in the Clinic, and the Latest Bench-to-Bedside Developments. Part 2: Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics. 2022;11. doi: 10.3389\/fonc.2021.811425.","DOI":"10.3389\/fonc.2021.811425"},{"key":"10.1016\/j.radonc.2023.109694_b0030","series-title":"Molecular Imaging in Oncology","first-page":"719","article-title":"Clinical MR Biomarkers","author":"Paech","year":"2020"},{"key":"10.1016\/j.radonc.2023.109694_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40658-016-0155-2","article-title":"An overview of CEST MRI for non-MR physicists","volume":"3","author":"Wu","year":"2016","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.radonc.2023.109694_b0040","doi-asserted-by":"crossref","unstructured":"von Knebel Doeberitz N, Maksimovic S, Loi L, Paech DJDR. \u201eChemical exchange saturation transfer \u201c(CEST). 2021;61:43-51","DOI":"10.1007\/s00117-020-00786-z"},{"key":"10.1016\/j.radonc.2023.109694_b0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neuroimage.2015.02.040","article-title":"Relaxation-compensated CEST-MRI of the human brain at 7T: unbiased insight into NOE and amide signal changes in human glioblastoma","volume":"112","author":"Zaiss","year":"2015","journal-title":"Neuroimage"},{"key":"10.1016\/j.radonc.2023.109694_b0050","doi-asserted-by":"crossref","unstructured":"Zhou J, Zaiss M, Knutsson L, Sun PZ, Ahn SS, Aime S, Bachert P, Blakeley JO, Cai K, Chappell MAJMRiM. Review and consensus recommendations on clinical APT\u2010weighted imaging approaches at 3T: Application to brain tumors. 2022.","DOI":"10.1002\/mrm.29241"},{"key":"10.1016\/j.radonc.2023.109694_b0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ijrobp.2018.03.057","article-title":"Evaluation of glioblastoma response to therapy with chemical exchange saturation transfer","volume":"101","author":"Mehrabian","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109694_b0060","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/noy073","article-title":"Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T","volume":"20","author":"Paech","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2023.109694_b0065","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1007\/s00330-019-06066-2","article-title":"Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients","volume":"29","author":"Paech","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2023.109694_b0070","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1007\/s00330-019-06203-x","article-title":"Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma","volume":"29","author":"Joo","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2023.109694_b0075","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jmri.25159","article-title":"Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas","volume":"44","author":"Ma","year":"2016","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2023.109694_b0080","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1148\/radiol.2015142979","article-title":"Pre- and posttreatment glioma: comparison of amide proton transfer imaging with MR spectroscopy for biomarkers of tumor proliferation","volume":"278","author":"Park","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2023.109694_b0085","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s00330-016-4261-2","article-title":"Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma","volume":"26","author":"Park","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.radonc.2023.109694_b0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00234-020-02542-5","article-title":"Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters","volume":"63","author":"Park","year":"2021","journal-title":"Neuroradiology"},{"key":"10.1016\/j.radonc.2023.109694_b0095","doi-asserted-by":"crossref","first-page":"28772","DOI":"10.18632\/oncotarget.25594","article-title":"Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients","volume":"9","author":"Regnery","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2023.109694_b0100","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jmri.26702","article-title":"Early response assessment of glioma patients to definitive chemoradiotherapy using chemical exchange saturation transfer imaging at 7 T","volume":"50","author":"Meissner","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2023.109694_b0105","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jmri.26900","article-title":"Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T","volume":"51","author":"Liu","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2023.109694_b0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-020-03661-y","article-title":"Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation","volume":"151","author":"Chan","year":"2021","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109694_b0115","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/s41598-018-20624-6","article-title":"Quantitative magnetization transfer in monitoring glioblastoma (GBM) response to therapy","volume":"8","author":"Mehrabian","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2023.109694_b0120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jmri.26645","article-title":"APT-weighted MRI: techniques, current neuro applications, and challenging issues","volume":"50","author":"Zhou","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2023.109694_b0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mrm.27751","article-title":"Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T","volume":"82","author":"Goerke","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2023.109694_b0130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2023.109694_b0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-014-1669-x","article-title":"Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945","volume":"121","author":"Eisenstat","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.radonc.2023.109694_b0140","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/mrm.27569","article-title":"3D gradient echo snapshot CEST MRI with low power saturation for human studies at 3T","volume":"81","author":"Deshmane","year":"2019","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2023.109694_b0145","doi-asserted-by":"crossref","first-page":"e3879","DOI":"10.1002\/nbm.3879","article-title":"Snapshot-CEST: Optimizing spiral-centric-reordered gradient echo acquisition for fast and robust 3D CEST MRI at 9.4 T","volume":"31","author":"Zaiss","year":"2018","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109694_b0150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/mrm.26133","article-title":"Simultaneous mapping of water shift and B1 (WASABI)-Application to field-Inhomogeneity correction of CEST MRI data","volume":"77","author":"Schuenke","year":"2017","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.radonc.2023.109694_b0155","doi-asserted-by":"crossref","first-page":"e4720","DOI":"10.1002\/nbm.4720","article-title":"Motion correction for three-dimensional chemical exchange saturation transfer imaging without direct water saturation artifacts","volume":"35","author":"Breitling","year":"2022","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109694_b0160","doi-asserted-by":"crossref","first-page":"e4133","DOI":"10.1002\/nbm.4133","article-title":"Adaptive denoising for chemical exchange saturation transfer MR imaging","volume":"32","author":"Breitling","year":"2019","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109694_b0165","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/nbm.3283","article-title":"Correction of B1-inhomogeneities for relaxation-compensated CEST imaging at 7 T","volume":"28","author":"Windschuh","year":"2015","journal-title":"NMR Biomed"},{"key":"10.1016\/j.radonc.2023.109694_b0170","doi-asserted-by":"crossref","unstructured":"Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQJJoCO. Response assessment in neuro-oncology clinical trials. 2017;35:2439","DOI":"10.1200\/JCO.2017.72.7511"},{"key":"10.1016\/j.radonc.2023.109694_b0175","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.18632\/oncotarget.13970","article-title":"Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas","volume":"8","author":"Bai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2023.109694_b0180","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.mam.2012.02.003","article-title":"The disturbed blood-brain barrier in human glioblastoma","volume":"33","author":"Wolburg","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.radonc.2023.109694_b0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.radonc.2023.109694_b0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mrm.25581","article-title":"Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semi-solid magnetization transfer reference (EMR) signals: application to a rat glioma model at 4.7 Tesla","volume":"75","author":"Heo","year":"2016","journal-title":"Magn Reson Med"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023002323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:51Z","timestamp":1759123611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023002323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":38,"alternative-id":["S0167814023002323"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109694","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CEST imaging of the APT and ssMT predict the overall survival of patients with glioma at the first follow-up after completion of radiotherapy at 3T","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109694"}}